Delivery Order SPE2DR25D2206-SPE2DR26F9KL3
Award Date 1/9/26
Potential Completion Date 2/2/26
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp for 420 mg Imbruvica tablets (quantity: 28 units) on November 20, 2025, with completion scheduled for December 12, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on August 15, 2025, for the supply of Imbruvica 280 mg tablets (quantity: 28 units) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The order is non-set-aside and competitively awarded, with an ultimate completion date of September 8, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count units) on November 18, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price, non-set-aside delivery order is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $41,312.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 28 tablets of Imbruvica 420 mg on January 2, 2026, with a completion date of January 26, 2026. This is a non-set-aside, competitively awarded contract issued as a child order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $47,902.08 delivery order to AmerisourceBergen Drug Corp for 28 tablets of Imbruvica 420 mg, a pharmaceutical product commonly used in oncology treatment. This firm fixed price contract, issued on December 17, 2025, is scheduled for completion by January 9, 2026 and represents a non-set-aside, competitively awarded procurement. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28 count) on June 6, 2025, with completion targeted for June 30, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on April 22, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by May 13, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Imbruvica 420 mg tablets (28-count packaging) with a contract ceiling value of $15,151.52. This is a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, representing a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was competitively awarded with no set-aside designation, and performance...